This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (201) JMIR Theme Issue: COVID-19 Special Issue (1725) Infectious Diseases (non-STD/STI) (1126) Outbreak and Pandemic Preparedness and Management (1276)

Published on in Vol 9, No 10 (2020): October

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/23543, first published .
Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study

Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study

Safety and Efficacy of Convalescent Plasma to Treat Severe COVID-19: Protocol for the Saudi Collaborative Multicenter Phase II Study

Authors of this article:

Mohammed Albalawi 1 Author Orcid Image ;   Syed Ziauddin Ahmed Zaidi 2 Author Orcid Image ;   Nawal AlShehry 2 Author Orcid Image ;   Ahmed AlAskar 3 Author Orcid Image ;   Abdul Rehman Zia Zaidi 4 Author Orcid Image ;   Rania Nagib Mohammed Abdallah 5 Author Orcid Image ;   Abdul Salam 6 Author Orcid Image ;   Ahmed AlSagheir 7 Author Orcid Image ;   Nour AlMozain 8 Author Orcid Image ;   Ghada Elgohary 9 Author Orcid Image ;   Khalid Batarfi 10 Author Orcid Image ;   Alia Alfaraedi 11 Author Orcid Image ;   Osamah Khojah 11 Author Orcid Image ;   Rehab Al-Ansari 12 Author Orcid Image ;   Mona Alfaraj 13 Author Orcid Image ;   Afra Dayel 14 Author Orcid Image ;   Ahmed Al Bahrani 15 Author Orcid Image ;   Arwa Nabhan Abdelhameed 16 Author Orcid Image ;   Hind Alhumaidan 17 Author Orcid Image ;   Jawaher M Al-Otaibi 18 Author Orcid Image ;   Ghazala Radwi 19 Author Orcid Image ;   Abdulrahman Raizah 3 Author Orcid Image ;   Hind Shatry 3 Author Orcid Image ;   Sara Alsaleh 7 Author Orcid Image ;   Hazzaa AlZahrani 20 Author Orcid Image ;   Hani Al-Hashmi 21 Author Orcid Image
Article Authors Cited by (5) Tweetations (41) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.